WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola

The World Health Organization has launched its first clinical trial to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola. According to France 24, the trial began on Tuesday in the Democratic Republic of Congo, where the outbreak continues to outpace response efforts. Officials say the virus has spread beyond known chains of transmission, raising the stakes for a preventive treatment that could protect those most at risk of exposure.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton